Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
1,442,780
-
Share change
-
+222,151
-
Total reported value
-
$2,163,000
-
Price per share
-
$1.50
-
Number of holders
-
11
-
Value change
-
+$321,557
-
Number of buys
-
3
-
Number of sells
-
6
Institutional Holders of AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) as of Q4 2021
As of 31 Dec 2021,
AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,442,780 shares.
The largest 10 holders included
Omnia Family Wealth, LLC, NEA Management Company, LLC, WSFS CAPITAL MANAGEMENT, LLC, Hikari Power Ltd, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Cetera Advisor Networks LLC, PNC Financial Services Group, Inc., MORGAN STANLEY, and BANK OF AMERICA CORP /DE/.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.